| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |